Evangelos michelakis biography of abraham

Evangelos D Michelakis,.

  • Evangelos D Michelakis,.
  • References.
  • Evangelos ANASTASAKIS | Cited by 29 | of University College London, London (UCL) | Read 4 publications | Contact Evangelos ANASTASAKIS.
  • Inventors of this patent are Drs. Evangelos Michelakis and SA. The authors do not have other conflicts of interest.
  • Methods/Results: We studied mitochondrial membrane potential, a surrogate for mitochondrial function, in human (n 5 11) and rat hearts with physiologic.

    • Evangelos ANASTASAKIS | Cited by 29 | of University College London, London (UCL) | Read 4 publications | Contact Evangelos ANASTASAKIS..

    New Possibility for Brain Tumour Treatment


    University of Alberta researchers are using an unpatented drug to change the metabolism of cancer cells, giving new hope to patients with some of the deadliest forms of brain cancer.

    The research team, led by Dr.

    Evangelos Michelakis, a professor in the department of medicine, tested dichloroacetate (DCA) on five patients with advanced forms of brain cancer. The team found that tumours in four of five patients either regressed, or stopped growing.

    Dr.

    Michelakis says the study “doesn’t lend any strong evidence to say that the drug is safe or efficacious.” Michelakis says, instead, that the study was meant to show a new mechanism for treating tumours – by targeting the tumours’ metabolism.

    DCA is a water-soluble powder that is taken orally.

    It can change the metabolism of gliobastoma brain tumour cells, which Dr. Michelakis describes as “one of the deadliest forms of cancer.” Though the study was not designed to show DCA is a cure for c